IND Swift Laboratories

IND Swift Laboratories EPS

The Earnings per Share (EPS) of IND Swift Laboratories (INDSWFTLAB.NS) as of Oct 19, 2026 is 4.77 INR. In the previous year, Earnings per Share (EPS) was 29.67 INR — a change of -83.93% (lower).

EPS

4.77INR

YoY

-83.93%

Last updated:

Earnings per Share (EPS) of IND Swift Laboratories is 2026 4.77 INR. Earnings per Share (EPS) of IND Swift Laboratories was 2025 29.67 INR. It decreases by -83.93% lower compared to the previous year.

The IND Swift Laboratories EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2019
6.07 INR
Jan 1, 2020
-3.58 INR
Jan 1, 2021
-0.53 INR
Jan 1, 2022
-0.36 INR
Jan 1, 2023
8.06 INR
Jan 1, 2024
71.24 INR
Jan 1, 2025
29.67 INR
Jan 1, 2026
4.77 INR
The IND Swift Laboratories EPS history
YEAREPSYoY
4.77INR-83.93%
29.67INR-58.35%
71.24INR+783.49%
8.06INR-2,319.01%
-0.36INR-31.70%
-0.53INR-85.13%
-3.58INR-158.96%
6.07INR+46.98%
4.13INR-191.61%
-4.51INR-33.32%
-6.76INR-50.83%
-13.75INR-2.17%
-14.05INR-52.89%
-29.82INR-231.36%
22.70INR+120.38%
10.30INR+58.66%
6.49INR+39.60%
4.65INR+28.55%
3.62INR+72.28%
2.10INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

IND Swift Laboratories Stock analysis

What does IND Swift Laboratories do? IND Swift Laboratories Ltd is a pharmaceutical company based in Chandigarh, India, operating within the healthcare sector. The company specializes in the manufacturing, development, and marketing of pharmaceutical ingredients, including intermediates and formulations. It employs 1,496 full-time employees and went public via an IPO on March 15, 2002. IND Swift Laboratories serves as an API (Active Pharmaceutical Ingredient) partner for various organizations in both generic and innovative pharmaceutical domains. The company provides reference standards and impurities for multiple active pharmaceutical ingredients (APIs), adhering to standards such as the British Pharmacopoeia (BP) and European Pharmacopoeia (EP). Its product portfolio includes over 25 APIs, with all impurities supplied alongside comprehensive documentation, including Certificates of Analysis and Material Safety Data Sheets (MSDS). The firm maintains a research center spanning 40,000 square feet, dedicated to developing process technology for APIs across various therapeutic categories. The company's website is www.indswiftlabs.com, and it operates under the ticker symbol INDSWFTLAB.NS with ISIN INE915B01019. IND Swift Laboratories focuses on supplying high-quality pharmaceutical components to support global pharmaceutical manufacturing needs. IND Swift Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IND Swift Laboratories stock

Earnings per Share (EPS) of IND Swift Laboratories is 4.77 INR in 2026.

Earnings per Share (EPS) of IND Swift Laboratories changed from 29.67 INR to 4.77 INR, representing a -83.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) IND Swift Laboratories since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — IND Swift Laboratories

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — IND Swift Laboratories